Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
11 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 27(3); June 2011
Prev issue Next issue
Editorials
Are Mutations of the EGFR Gene Promising Predictive Markers for Anti-EGFR mAbs in Colorectal Carcinomas?
Dong-Guk Park
J Korean Soc Coloproctol. 2011;27(3):103-104.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.103
  • 2,194 View
  • 26 Download
PDF
Prognostic Role of MMPs in Colorectal Cancer
Moo-Jun Baek
J Korean Soc Coloproctol. 2011;27(3):105-106.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.105
  • 3,022 View
  • 19 Download
  • 3 Citations
PDF

Citations

Citations to this article as recorded by  
  • Plasma and wound fluid levels of eight proangiogenic proteins are elevated after colorectal resection
    HMC Shantha Kumara, Xiao-Hong Yan, Erica Pettke, Vesna Cekic, Nipa Dilip Gandhi, Geoffrey A Bellini, Richard L Whelan
    World Journal of Gastrointestinal Oncology.2019; 11(6): 470.     CrossRef
  • Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males
    Mahmood Rasool, Arif Malik, Ahmad Ashar Ghuman, Muhammad Abdul Basit Ashraf, Mahwish Arooj, Sulayman Waquar, Sara Zahid, Sumera Shaheen, Aamer Qazi, Muhammad Imran Naseer, Mazin A. Zamzami, Ayat Al-Ghafari, Othman A. Baothman, Mustafa Zeyadi, Nawal Helmi,
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication
    Zbigniew Lorenc, Dariusz Waniczek, Katarzyna Lorenc-Podgórska, Wiktor Krawczyk, Maciej Domagała, Mateusz Majewski, Urszula Mazurek
    Medical Science Monitor.2017; 23: 1305.     CrossRef
Review
Rectal Prolapse: Review According to the Personal Experience
Seo-Gue Yoon
J Korean Soc Coloproctol. 2011;27(3):107-113.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.107
  • 5,509 View
  • 69 Download
  • 20 Citations
AbstractAbstract PDF

The aim of treatment of rectal prolapse is to control the prolapse, restore continence, and prevent constipation or impaired evacuation. Faced with a multitude of options, the choice of an optimal treatment is difficult. It is best tailored to patient and surgeon. Numerous procedures have been described and are generally categorized into perineal or abdominal approaches. In general, an abdominal procedure has associated with lower recurrence and better functional outcome than perineal procedures. The widespread success of laparoscopic surgery has led to the development of laparoscopic procedures in the treatment of complete rectal prolapse. In Korea, there has been a trend toward offering perineal procedures because of the high incidence of rectal prolapse in young males and its being a lesser procedure. Delorme-Thiersch procedure has appeal as a lesser procedure for patients of any age or risk category, especially for elderly low-risk patients, patients with constipation or evacuation difficulties, young males, and patients with symptomatic hemorrhoids or mucosal prolapse. Laparoscopic suture rectopexy is recommended for either low-risk female patients or patients who are concerned with postoperative aggravation of their incontinence.

Citations

Citations to this article as recorded by  
  • A Case of Robotic Posterior Rectopexy for Full-thickness Rectal Prolapse
    Shinsuke Suzuki, Teni Godai, Shin Kato, Atsushi Onodera, Kazuya Endo, Shizune Onuma, Yui Honjo, Junya Shirai, Masakatsu Numata, Yutaka Kumakiri, Shinichiro Suzuki, Yuji Yamamoto
    Journal of the Anus, Rectum and Colon.2022; 6(1): 72.     CrossRef
  • A Case of Laparoscopic Rectopexy for Rectal Prolapse after Intersphincteric Resection
    Kensuke Nakamura, Hiromitsu Iwamoto, Kenji Matsuda, Yasuyuki Mitani, Yuki Mizumoto, Yuki Nakamura, Norio Takemoto, Toshihiro Sakanaka, Masato Tamiya, Hiroki Yamaue
    Nippon Daicho Komonbyo Gakkai Zasshi.2022; 75(2): 71.     CrossRef
  • Delorme surgery for colonic mucosal prolapse after intersphincteric resection
    Satoshi Narihiro, Naoko Miura, Yuji Nishizawa, Hiro Hasegawa, Koji Ikeda, Koichi Teramura, Yuichiro Tsukada, Takeshi Sasaki, Masaaki Ito
    Surgery Today.2021; 51(6): 916.     CrossRef
  • Factors Predicting the Presence of Concomitant Enterocele and Rectocele in Female Patients With External Rectal Prolapse
    Akira Tsunoda, Tomoko Takahashi, Kenji Sato, Hiroshi Kusanagi
    Annals of Coloproctology.2021; 37(4): 218.     CrossRef
  • Laparoscopic Sutureless Rectopexy Using a Fixation Device for Complete Rectal Prolapse
    Shinobu Tomochika, Nobuaki Suzuki, Shin Yoshida, Toshiyuki Fujii, Yukio Tokumitsu, Yoshitaro Shindo, Michihisa Iida, Shigeru Takeda, Shoichi Hazama, Hiroaki Nagano
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2021; 31(5): 608.     CrossRef
  • Laparoscopic Pelvic Organ Prolapse Suspension (Pops) Versus Laparoscopic Ventral Mesh Rectopexy for Treatment of Rectal Prolapse: Prospective Cohort Study
    Ahmed Farag, Abdrabou N. Mashhour, Mohamed Raslan, Mohamed Tamer, Mohamed Yehia Elbarmelgi
    World Journal of Surgery.2020; 44(9): 3158.     CrossRef
  • Short-Term Outcomes of Rectal Mucosa Sleeve Resection and Transverse Perineal Support Operation for Occult Rectal Prolapse, Rectocele and Descending Perineum: A Single Center and Single Team Experience
    Francesco Cantarella, Enrico Magni
    Annals of Colorectal Research.2019;[Epub]     CrossRef
  • Comparison of Delorme-Thiersch Operation Outcomes in Men and Women With Rectal Prolapse
    Keehoon Hyun, Seo-Gue Yoon
    Annals of Coloproctology.2019; 35(5): 262.     CrossRef
  • Usefulness of laparoscopic posterior rectopexy for complete rectal prolapse: A cohort study
    Hiroki Hashida, Masato Sato, Yukiko Kumata, Motoko Mizumoto, Masato Kondo, Hiroyuki Kobayashi, Takehito Yamamoto, Hiroaki Terajima, Satoshi Kaihara
    International Journal of Surgery.2019; 72: 109.     CrossRef
  • Surgical Treatment of Rectal Prolapse: A 10-Year Experience at a Single Institution
    Aeris Jane D. Nacion, Youn Young Park, Ho Seung Kim, Seung Yoon Yang, Nam Kyu Kim
    The Journal of Minimally Invasive Surgery.2019; 22(4): 164.     CrossRef
  • Laparoscopic Posterolateral Rectopexy for the Treatment of Patients With a Full Thickness Rectal Prolapse: Experience With 63 Patients and Short-term Outcomes
    Keehoon Hyun, Shi-Jun Yang, Ki-Yun Lim, Jong-Kyun Lee, Seo-Gue Yoon
    Annals of Coloproctology.2018; 34(3): 119.     CrossRef
  • Conservative management of septic complication after internal Delorme procedure for occult rectal prolapse and rectocele in obstructed defecation syndrome
    F. Cantarella, E. Magni
    Techniques in Coloproctology.2018; 22(10): 817.     CrossRef
  • Thiersch Procedure for Rectal Prolapse: Experiences From a Single Institution
    Ren-Hao Chan, Bo-Wen Lin, Shao-Chieh Lin, Jenq-Chang Lee
    International Surgery.2017; 102(1-2): 10.     CrossRef
  • Laparoscopic ventral mesh rectopexy vs Delorme's operation in management of complete rectal prolapse: a prospective randomized study
    S. H. Emile, H. Elbanna, M. Youssef, W. Thabet, W. Omar, A. Elshobaky, T. M. Abd El‐Hamed, M. Farid
    Colorectal Disease.2017; 19(1): 50.     CrossRef
  • Emergency Perineal Rectosigmoidectomy for Gangrenous Rectal Prolapse: a Single-Centre Experience with Review of Literature
    Vijay Dattatraya Borgaonkar, Sushil Sharad Deshpande, Viraj Vijay Borgaonkar, Mukesh Dhondiram Rathod
    Indian Journal of Surgery.2017; 79(1): 45.     CrossRef
  • Simultaneous Delorme's procedure and inter-sphinteric prosthetic implant for the treatment of rectal prolapse and faecal incontinence: Preliminary experience and literature review
    Emanuel Cavazzoni, Emanuele Rosati, Valentina Zavagno, Luigina Graziosi, Annibale Donini
    International Journal of Surgery.2015; 14: 45.     CrossRef
  • Laparoscopy for pelvic floor disorders
    B. Van Geluwe, A. Wolthuis, A. D'Hoore
    Best Practice & Research Clinical Gastroenterology.2014; 28(1): 69.     CrossRef
  • Combined Aluminum Potassium Sulfate and Tannic Acid Sclerosing Therapy and Anal Encirclement Using an Elastic Artificial Ligament for Rectal Prolapse
    Tatsuya Abe, Yoshikazu Hachiro, Masao Kunimoto
    Diseases of the Colon & Rectum.2014; 57(5): 653.     CrossRef
  • Comparison of abdominal and perineal procedures for complete rectal prolapse: an analysis of 104 patients
    Jong Lyul Lee, Sung Soo Yang, In Ja Park, Chang Sik Yu, Jin Cheon Kim
    Annals of Surgical Treatment and Research.2014; 86(5): 249.     CrossRef
  • Procedures and Outcomes of Rectopexy for Rectal Prolapse
    Yoshikazu Koide, Koutarou Maeda, Tsunekazu Hanai, Harunobu Satou, Kouji Masumori, Hiroshi Matsuoka, Hidetoshi Katsuno, Miho Siota, Tomoyoshi Endou, Shingi Matsuoka, Kouhei Hatta, Masahiro Mizuno, Kunihiro Tooyama
    Nippon Daicho Komonbyo Gakkai Zasshi.2012; 65(10): 840.     CrossRef
Original Articles
Clinical Characteristics of Primary Epiploic Appendagitis
Young Un Choi, Pyong Wha Choi, Yong Hwan Park, Jae Il Kim, Tae Gil Heo, Je Hoon Park, Myung Soo Lee, Chul Nam Kim, Surk Hyo Chang, Jeong Wook Seo
J Korean Soc Coloproctol. 2011;27(3):114-121.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.114
  • 5,429 View
  • 37 Download
  • 28 Citations
AbstractAbstract PDF
Purpose

Primary epiploic appendagitis (PEA) is a rare cause of an acute abdomen. It can be clinically misdiagnosed as either diverticulitis or appendicitis on clinical examination because the clinical symptoms and signs of PEA are non-specific. The present study was performed to describe the clinical characteristics of PEA and to assess the differences between PEA and diverticulitis.

Methods

We reviewed the clinical records and radiologic findings of 31 consecutive patients with PEA and compared them with those of patients with diverticulitis without complications.

Results

In most cases, abdominal pain was localized to the right (13 cases, 41.9%) or left (13 cases, 41.9%) lower quadrants. Gastrointestinal symptoms such as nausea and vomiting were infrequent, and localized tenderness without peritoneal irritation was common. All patients were afebrile, and only 4 patients (12.9%) showed leukocytosis. In all cases except one, a pericolic fatty mass with a hyperattenuated ring was observed on computed tomography. Patients with left PEA were younger than those with diverticulitis (41.4 ± 11.9 vs. 69.7 ± 13.3, P < 0.001), and the mean body mass index was higher in patients with left PEA (26.4 ± 2.9 vs. 22.6 ± 3.4, P = 0.01). Whereas one patient (6.7%) with left PEA showed leukocytosis, the incidence of leukocytosis in patients with diverticulitis was 80% (8/10) (P < 0.001).

Conclusion

In patients with an acute abdomen showing localized tenderness without associated symptoms or leukocytosis, a high index of suspicion for PEA is necessary. For correct diagnosis and proper management, it would useful for surgeons to be aware of the computed tomographic findings and the natural course of the disease.

Citations

Citations to this article as recorded by  
  • Diagnosis and treatment of epiploic appendagitis in a Middle Eastern country: An observational retrospective analysis of 156 cases
    Ayman El‐Menyar, Syed G. A. Naqvi, Omer Al‐Yahri, Abdelaziz MA Abusal, Abdulwahhab Al‐Shaikhli, Sadia Sajid, Husham Abdelrahman, Ahmad G. Kloub, Muhamed Ibnas, Rifat Latifi, Yasser M. R. Toble, Hassan Al‐Thani
    World Journal of Surgery.2024; 48(6): 1363.     CrossRef
  • A Rare Presentation of Epiploic Appendagitis as Chest Pain: A Case Report
    Thomas A Elimihele, Sachin Kumar, Ifelunwa M Osanakpo, Nkechi Akata
    Cureus.2024;[Epub]     CrossRef
  • A False Alarm of Acute Abdomen: Epiploic Appendagitis Case Report and Literature Review
    Noor ul Huda Ramzan, Talha Asif, Mahnoor Tauqeer, Muhammad Bilal Hashmat, Mian Uman Anwer
    Cureus.2024;[Epub]     CrossRef
  • Recurrencia en pacientes con apendagitis epiploica: un reporte de caso
    Mía Alejandra Gómez Corrales, Fabian Andrés Chávez Ecos, Jackeline Alexandra Espinoza Utani, Carlos Alberto Dávila Hernández
    Revista colombiana de Gastroenterología.2023; 38(1): 94.     CrossRef
  • A Case of Epiploic Appendagitis after COVID-19
    Hun Joo Lee, Jaeyeon Kim, Seong O Suh
    The Korean Journal of Gastroenterology.2023; 81(3): 125.     CrossRef
  • A rare case of epiploic appendages infarction within an incisional hernia: a usual complain of unusual cause
    Elias Edward Lahham, Qusai A Alsalah, Mohammad I Alsahouri, Abdalrazeq Ghweir, Mohammad AlQadi, Nafez Sarhan
    Journal of Surgical Case Reports.2023;[Epub]     CrossRef
  • Primary epiploic appendagitis: A retrospective analysis of clinical and tomographic findings in 14 patients
    Belma ÇEVİK, Benan KASAPOĞLU
    Archives of Current Medical Research.2023; 4(3): 186.     CrossRef
  • Appendagitis epiploica: eine seltene und nichtchirurgische Ursache abdomineller Schmerzen
    Ahmad Alhazmi, Cynthia de Carvalho Fischer, Lars-Arne Schaafs, Claudia Seifarth
    Die Chirurgie.2023; 94(11): 954.     CrossRef
  • Prevalence of SIRS with primary epiploic appendagitis
    Julian Wong, Kenneth K. Lau
    Emergency Radiology.2023; 31(1): 17.     CrossRef
  • EPIPLOIC APPENDAGITIS: AN UNCOMMON CASE OF ACUTE ABDOMINAL PAIN WITH CHARACTERISTIC IMAGING FINDINGS.
    Shreyas C, Ankita Chauhan, Sanjeev Sharma
    INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2022; : 23.     CrossRef
  • A Case of Recurrent Epiploic Appendagitis Treated With Conservative Management
    Rachel V Christenson, Phuoc D Nguyen, Lincoln R Wallace
    Cureus.2022;[Epub]     CrossRef
  • Intraperitoneal focal fat infarction: the great mimicker in the acute setting
    Eleni Lazaridou, Christina Aslanidi, Vassiliki Mellou, Sofia Athanasiou, Demetrios Exarhos
    Emergency Radiology.2021; 28(1): 201.     CrossRef
  • Epiploic Appendagitis
    Yuta Hirose, Kiyoshi Shikino
    The American Journal of Medicine.2021; 134(3): e195.     CrossRef
  • Primary Epiploic Appendagitis: A Case Report
    Alpaslan Mert, Emre Mırcık
    Cureus.2021;[Epub]     CrossRef
  • Primary Epiploic Appendagitis Mimicking Acute Appendicitis: A Case Report and Narrative Review of the Literature
    Maria Alexandra Kefala, Kostas Tepelenis, Christos K. Stefanou, Stefanos K. Stefanou, Georgios Papathanakos, Aikaterini Kitsouli, Nikolaos Tepelenis, Panagiotis Kitsoulis
    The Korean Journal of Gastroenterology.2020; 76(2): 88.     CrossRef
  • Clinical Awareness and Acceptance of Sonographically Diagnosed Epiploic Appendagitis (EA): A Retrospective Analysis of EA in a Single Tertiary Academic Referral Center
    Ehsan Safai Zadeh, Julia Kindermann, Christoph F. Dietrich, Christian Görg, Tobias Bleyl, Amjad Alhyari, Corinna Trenker
    Ultrasound International Open.2020; 06(03): E87.     CrossRef
  • THE INFLAMMATION OF EPIPLOIC APPENDIX: PRIMARY EPIPLOIC APPENDAGITIS
    Sevilay VURAL, Figen COŞKUN
    Kırıkkale Üniversitesi Tıp Fakültesi Dergisi.2019; 21(1): 102.     CrossRef
  • Primary epiploic appendagitis as an unusual cause of acute abdominal pain in a middle-aged male
    Lan Yang, Min Jia, Ping Han
    Medicine.2019; 98(33): e16846.     CrossRef
  • Primary epiploic appendagitis: compared with diverticulitis and focused on obesity and recurrence
    Youn I Choi, Hyun Sun Woo, Jun-Won Chung, Young Sup Shim, Kwang An Kwon, Kyoung Oh Kim, Yoon Jae Kim, Dong Kyun Park
    Intestinal Research.2019; 17(4): 554.     CrossRef
  • CT imaging findings of epiploic appendagitis: an unusual cause of abdominal pain
    Dario Giambelluca, Roberto Cannella, Giovanni Caruana, Leonardo Salvaggio, Emanuele Grassedonio, Massimo Galia, Massimo Midiri, Giuseppe Salvaggio
    Insights into Imaging.2019;[Epub]     CrossRef
  • NADİR GÖRÜLEN BİR AKUT ABDOMEN SEBEBİ: EPİPLOİK APANDİSİT
    Mehmet Şirik, Sabri Özdaş
    Adıyaman Üniversitesi Sağlık Bilimleri Dergisi.2018; : 51.     CrossRef
  • Epiploic appendagitis masquerading as incarcerated left inguinal hernia
    Constantinos Avgoustou, M. Sioula
    Hellenic Journal of Surgery.2016; 88(3): 205.     CrossRef
  • An unusual cause of hematuria; primary epiploic appendagitis
    Basri Cakiroglu, Orhun Sinanoglu, İlker Abci, Tuncay Tas, Akif Nuri Dogan, Suleyman Hilmi Aksoy, Yilmaz Bilsel
    International Journal of Surgery Case Reports.2014; 5(12): 902.     CrossRef
  • Primary epiploic appendagitis: Reconciling CT and clinical challenges
    Jamel Saad, Hussein Ali Mustafa, Asem Mohamed Elsani, Fawaz Alharbi, Saad Alghamdi
    Indian Journal of Gastroenterology.2014; 33(5): 420.     CrossRef
  • Torsion of epiploic appendix presenting as acute pancreatitis
    Charles Greenbury, Peter Thurley, Altaf Awan
    JRSM Open.2014;[Epub]     CrossRef
  • Is Outpatient Follow-Up of Epiploic Appendagitis with NSAIDs Alone and Noantibiotics Possible?
    Mehmet İlhan, Erçin Sönmez, Kaan Gök, Hakan Yanar, Recep Güloğlu, Kayhan Günay, Cemalettin Ertekin
    Open Journal of Gastroenterology.2014; 04(04): 170.     CrossRef
  • Primary epiploic appendagitis
    Carlos Augusto Real Martinez, Rogério Tadeu Palma, Paulo Pedroso Silveira Júnior, Daniela Tiemi Sato, Murilo Rocha Rodrigues, Hermínio Cabral de Resende Júnior, René Crepaldi Filho
    Journal of Coloproctology.2013; 33(03): 161.     CrossRef
  • Epiploic appendagitis: An uncommon cause of acute abdomen
    PankajKumar Garg, Rajiv Verma, BhupendraKumar Jain, Seema Aggarwal
    Annals of African Medicine.2013; 12(4): 257.     CrossRef
Diagnostic Value of C-reactive Protein in Complicated Appendicitis
Hyoung-Min Moon, Beom-Seok Park, Duk-Jin Moon
J Korean Soc Coloproctol. 2011;27(3):122-126.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.122
  • 3,543 View
  • 44 Download
  • 20 Citations
AbstractAbstract PDF
Purpose

Early detection of appendicitis has increased due to development of computed tomography and ultrasonography, yet we are frequently meeting complicated appendicitis, including perforation, abscess and a gangrenous appendicitis due to delayed diagnosis. For that reason, we want to evaluate predictive factors for the complicated appendicitis.

Methods

A total of 128 patients with appendicitis, after 13 patients with a duration of under 12 hours and 15 patients with pathological non-appendicitis were excluded from 156 patients, who visited Kwangju Christian Hospital from November 2008 to November 2010 were retrospectively reviewed.

Results

There were 62 patients (48.3%) with simple appendicitis and 66 patients (51.7%) with complicated appendicitis. In univariate analysis, age (P < 0.001), C-reactive protein (P < 0.001) and the diameter of the appendix (P = 0.006), were found to be significant. Multivariate analysis demonstrated that C-reactive protein was an independent predictor for complicated appendicitis (odds ratio, 1.371; 95% confidence interval, 1.155 to 1.628; P < 0.001). The cut-off value of C-reactive protein was set at 7.05 mg/dL by using receiver operating characteristic curve (0.805; sensitivity, 57.6%; specificity, 98.3%).

Conclusion

This study suggests that if C-reactive protein is above 7.05 mg/dL, immediate and proper management should be performed due to a high probability of complicated appendicitis, especially in young children or elderly patients who frequently present with vague symptoms.

Citations

Citations to this article as recorded by  
  • Usefulness of extended inflammatory parameters related to neutrophil activation reported by Sysmex XN-1000 hematology analyzer for predicting complicated acute appendicitis. Comparison with canonical inflammatory laboratory tests
    María Isabel Díaz López, Elena Crespo Álvarez, Álvaro Martínez Manzano, Eloísa Urrechaga, Manuel Tomás Orgaz Morales, Mercedes González Morales, Elena Martín García, Luis García de Guadiana-Romualdo
    Cirugía Española (English Edition).2024; 102(6): 300.     CrossRef
  • Usefulness of extended inflammatory parameters related to neutrophil activation reported by Sysmex XN-1000 hematology analyzer for predicting complicated acute appendicitis. Comparison with canonical inflammatory laboratory tests
    María Isabel Díaz López, Elena Crespo Álvarez, Álvaro Martínez Manzano, Eloísa Urrechaga, Manuel Tomás Orgaz Morales, Mercedes González Morales, Elena Martín García, Luis García de Guadiana-Romualdo
    Cirugía Española.2024; 102(6): 300.     CrossRef
  • Predicting complicated appendicitis is possible without the use of sectional imaging—presenting the NoCtApp score
    Jens Strohäker, Martin Brüschke, You-Shan Feng, Christian Beltzer, Alfred Königsrainer, Ruth Ladurner
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Individual biomarkers in the blood are not yet applicable in diagnosing complicated appendicitis: A scoping review
    Binyamin Sikander, Jacob Rosenberg, Siv Fonnes
    The American Journal of Emergency Medicine.2023; 67: 100.     CrossRef
  • MONOCYTE DISTRIBUTION WIDTH; CAN IT BE USED AS AN EARLY DIAGNOSIS MARKER IN CASES OF ACUTE COMPLICATED APPENDICITIS? A PRELIMINARY STUDY
    Koray KOŞMAZ, Abdullah DURHAN, Abdullah ŞENLİKCİ, Marlen SÜLEYMAN, Can ERSAK, Ender ERGÜDER, Yusuf Murat BAG, Mehmet ŞENEŞ, Mevlüt Recep PEKCİCİ
    Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi.2022; 54(3): 424.     CrossRef
  • Inflammatory parameters as predictive factors for complicated appendicitis: A retrospective cohort study
    Ana Matos Ribeiro, Inês Romero, Carlos Costa Pereira, Filomena Soares, Álvaro Gonçalves, Susana Costa, João Barros da Silva
    Annals of Medicine and Surgery.2022; 74: 103266.     CrossRef
  • Comment to: “Inflammatory parameters as predictive factors for complicated appendicitis: A retrospective cohort study’’
    Rıfat Peksöz, Yavuz Albayrak, Sabri Selçuk Atamanalp
    Annals of Medicine and Surgery.2022; 75: 103391.     CrossRef
  • The potential role of interleukin-6, endotoxin and C-reactive protein as standard biomarkers for acute appendicitis in adults
    Sasa Dimic, Ivana Dimic, Zlatan Elek, Milan Radojkovic
    Srpski arhiv za celokupno lekarstvo.2022; 150(3-4): 163.     CrossRef
  • Characteristics of Patients Presented with Complicated Appendicitis in Adama, Ethiopia: A Cross-Sectional Study
    Haset Dagne, Tsega-Ab Abebaw
    Open Access Emergency Medicine.2022; Volume 14: 573.     CrossRef
  • Conversion rate and risk factors of conversion to open in laparoscopic appendicectomy
    Nelson Rao Pushpanathan, Mohd Nizam Md Hashim, Zalina Zahari, Syed Hassan Syed Abd. Aziz, Wan Zainira Wan Zain, Rosnelifaizur Ramely, Michael Pak-Kai Wong, Ikhwan Sani Mohamad, Wan Mokhzani Wan Mokhter, Maya Mazuwin Yahya, Siti Rahmah Hashim Isa Merican,
    Annals of Coloproctology.2022; 38(6): 409.     CrossRef
  • Comparison of Outer Diameter of Appendix, C-reactive Protein, and Serum Bilirubin Levels in Complicated Versus Uncomplicated Appendicitis
    Dhanish Parekh, Dinesh Jain, Saurabh Mohite, Deepak Phalgune
    Indian Journal of Surgery.2020; 82(3): 314.     CrossRef
  • RIPASA and air scoring systems are superior to alvarado scoring in acute appendicitis: Diagnostic accuracy study
    Meer M. Chisthi, Anilkumar Surendran, Jiju Therumpurathu Narayanan
    Annals of Medicine and Surgery.2020; 59: 138.     CrossRef
  • Risk factors for serious morbidity, prolonged length of stay and hospital readmission after laparoscopic appendectomy - results from Pol-LA (Polish Laparoscopic Appendectomy) multicenter large cohort study
    Maciej Walędziak, Anna Lasek, Michał Wysocki, Michael Su, Maciej Bobowicz, Piotr Myśliwiec, Kamil Astapczyk, Mateusz Burdzel, Karolina Chruściel, Rafał Cygan, Wojciech Czubek, Natalia Dowgiałło-Wnukiewicz, Jakub Droś, Paula Franczak, Wacław Hołówko, Artur
    Scientific Reports.2019;[Epub]     CrossRef
  • Utility of the immature granulocyte percentage for diagnosing acute appendicitis among clinically suspected appendicitis in adult
    Jae‐Sang Park, June‐Sung Kim, Youn‐Jung Kim, Won Young Kim
    Journal of Clinical Laboratory Analysis.2018;[Epub]     CrossRef
  • ROLE OF C REACTIVE PROTEIN AND WBC COUNT IN THE DIAGNOSIS OF ACUTE APPENDICITIS AND ITS PREDICTIVE VALUE IN ASSESSING THE SEVERITY OF THE DISEASE
    Jeyaraman V, Arjun Pon Avudaiappan
    Journal of Evidence Based Medicine and Healthcare.2017; 4(5): 248.     CrossRef
  • A scoring system to predict the severity of appendicitis in children
    Ramon R. Gorter, Anne Loes van den Boom, Hugo A. Heij, C.M. Frank Kneepkens, Caroline C. Hulsker, Mark Tenhagen, Imro Dawson, Johanna H. van der Lee
    Journal of Surgical Research.2016; 200(2): 452.     CrossRef
  • Surgeon's clinical valuation and accuracy of ultrasound in the diagnosis of acute appendicitis: A comparison with intraoperative evaluation. Five years experience
    Alessia Ferrarese, Alessandro Falcone, Mario Solej, Dario Bono, Paolo Moretto, Najada Dervishi, Veltri Andrea, Stefano Enrico, Mario Nano, Valter Martino
    International Journal of Surgery.2016; 33: S45.     CrossRef
  • Is preoperative distinction between complicated and uncomplicated acute appendicitis feasible without imaging?
    Elina Lietzén, Jari Mällinen, Juha M. Grönroos, Tero Rautio, Hannu Paajanen, Pia Nordström, Markku Aarnio, Tuomo Rantanen, Juhani Sand, Jukka-Pekka Mecklin, Airi Jartti, Johanna Virtanen, Pasi Ohtonen, Paulina Salminen
    Surgery.2016; 160(3): 789.     CrossRef
  • The impact of disease severity, age and surgical approach on the outcome of acute appendicitis in children
    A. L. van den Boom, R. R. Gorter, P. M. M. van Haard, P. G. Doornebosch, H. A. Heij, I. Dawson
    Pediatric Surgery International.2015; 31(4): 339.     CrossRef
  • Could C-Reactive Protein be a Potential Biomarker of Complicated Acute Appendicitis?
    Cy Lai, Yk Leung, Ca Graham
    Hong Kong Journal of Emergency Medicine.2014; 21(6): 354.     CrossRef
Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
Bo-Young Oh, Ryung-Ah Lee, Soon-Sup Chung, Kwang Ho Kim
J Korean Soc Coloproctol. 2011;27(3):127-132.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.127
  • 3,367 View
  • 33 Download
  • 15 Citations
AbstractAbstract PDF
Purpose

The epidermal growth factor receptor (EGFR) plays an important role in tumorigenesis and tumor progression of colorectal cancer and leads to the activation of intracellular signaling pathways. The use of anti-EGFR-targeted therapy has increased for patients with colorectal cancer, but patients with EGFR mutations will be resistant to anti-EGFR-targeted therapy. The identification of gene mutations is critical in cancer treatment; therefore, the aim of this study is to investigate the incidences of EGFR mutations in colorectal cancer patients in Korea.

Methods

We retrospectively reviewed 58 colorectal cancer patients who underwent surgery between 2003 and 2006. We analyzed their EGFR mutations in four loci by DNA sequencing. In addition, we analyzed the correlation between the presence of EGFR mutation and patients' clinicopathologic features.

Results

Of the 58 patients, 35 patients were male and 23 were female. Their mean age was 63.28 ± 11.18 years. Two patients (3.45%) were diagnosed as stage Tis, 7 patients (12.07%) as stage I, 24 patients (41.38%) as stage II, 20 patients (34.48%) as stage III, and 5 patients (8.62%) as stage IV. As a result of mutational analysis, EGFR mutations on exon 20 were detected in 13 patients (22.41%, G→A transitions). No EGFR mutations were detected on exons 18, 19, and 21. EGFR mutation was increased in the earlier stage and in the absence of lymph node metastasis (P = 0.028).

Conclusion

The incidence of EGFR mutation in Korean colorectal cancer patients is 22.41%. In addition, EGFR mutation was significantly increased in the earlier stage and in the absence of lymph node metastasis.

Citations

Citations to this article as recorded by  
  • Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data
    Nagasundaram Nagarajan, Chittibabu Guda
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics
    Claiborne W. Tydings, Bhuminder Singh, Adam W. Smith, Kaitlyn V. Ledwitch, Benjamin P. Brown, Christine M. Lovly, Allison S. Walker, Jens Meiler
    Protein Science.2024;[Epub]     CrossRef
  • Gut-associated lymphoid tissue carcinoma analyzed using next-generation sequencing: A case report
    Naomi Sato, Sadahide Ono, Kurodo Kamiya, Noriyuki Uesugi, Fumiyoshi Fujishima, Hiroshi Kawachi, Tamotsu Sugai
    Pathology - Research and Practice.2024; 263: 155621.     CrossRef
  • Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges
    Chiara Tramontano, Luca De Stefano, Ilaria Rea
    Marine Drugs.2023; 21(5): 266.     CrossRef
  • Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of Curcuma longa as Potential Lead Inhibitors of ERBB and VEGFR-2 for the Treatment of Colorectal Cancer
    Syeda Abida Ejaz, Mubashir Aziz, Mohamed Fawzy Ramadan, Ammara Fayyaz, Muhammad Sajjad Bilal
    Molecules.2023; 28(10): 4044.     CrossRef
  • Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings
    Dylan Haynes, Eric E. Morgan, Emily Y. Chu
    Human Pathology.2023; 140: 129.     CrossRef
  • Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response
    Tae Hoon Lee, Bum‐Sup Jang, Ji Hyun Chang, Eunji Kim, Jeong Hwan Park, Eui Kyu Chie
    Cancer Medicine.2023; 12(14): 15664.     CrossRef
  • Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives
    Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Agustin Pimentel, Jashodeep Datta, Alan S. Livingstone, Rodrigo Vianna, Phillipe Abreu
    Cancers.2023; 15(11): 3023.     CrossRef
  • NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes
    Ryan Timothy D. Yu, Reynaldo L. Garcia
    Scientific Reports.2020;[Epub]     CrossRef
  • Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling
    Alberto Izzotti, Chiara Ceccaroli, Marta Geretto, Filippo Grillo Ruggieri, Sara Schenone, Emilio Di Maria
    Cancers.2020; 12(6): 1652.     CrossRef
  • Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    Marcel Wiesweg, Stefan Kasper, Karl Worm, Thomas Herold, Henning Reis, Linda Sara, Martin Metzenmacher, Annalena Abendroth, Kaid Darwiche, Clemens Aigner, Heiner H. Wedemeyer, Fabian A. Helfritz, Martin Stuschke, Brigitte Schumacher, Peter Markus, Andreas
    Oncogene.2019; 38(16): 2953.     CrossRef
  • Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer
    Evangelos Koustas, Michalis V. Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G. Papavassiliou
    Cancer Letters.2017; 396: 94.     CrossRef
  • Lack of Mutations in Protein Tyrosine Kinase Domain Coding Exons 19 and 21 of the EGFR Gene in Oral Squamous Cell Carcinomas
    Dhaval Tushar Mehta, Thangavelu Annamalai, Arvind Ramanathan
    Asian Pacific Journal of Cancer Prevention.2014; 15(11): 4623.     CrossRef
  • Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis
    Shoude Zhang, Jia Chen, Hua Jiang, Haina Ma, Beibei Yang
    European Journal of Clinical Pharmacology.2012; 68(5): 561.     CrossRef
  • Are Mutations of the EGFR Gene Promising Predictive Markers for Anti-EGFR mAbs in Colorectal Carcinomas?
    Dong-Guk Park
    Journal of the Korean Society of Coloproctology.2011; 27(3): 103.     CrossRef
Matrix Metalloproteinase-2 and -7 Expression in Colorectal Cancer
Seong Woo Hong, Yun Kyung Kang, Byungmo Lee, Woo Yong Lee, Yeo Gu Jang, In Wook Paik, Hyucksang Lee
J Korean Soc Coloproctol. 2011;27(3):133-139.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.133
  • 4,461 View
  • 33 Download
  • 19 Citations
AbstractAbstract PDF
Purpose

Matrix metalloproteinase-2 (MMP-2) and MMP-7 have been implicated in tumor growth and metastasis. This study aimed to investigate the expressions of MMP-2 and -7 in colorectal cancer and to evaluate their values as prognostic markers.

Methods

Immunohistochemical staining for MMP-2 and -7 was done in 144 resected colorectal cancer specimens. Clinicopathological data and survival results were compared with regard to the expression results.

Results

The expression rates of MMP-2 in tumor cells in the tumor center and the tumor border were 16.7% and 38.9%, respectively. That of MMP-2 in stromal cells was 27.8%. MMP-7 immunoreactivities of tumor cells in the tumor center and the tumor border were 6.9% and 23.6%. The expressions of MMP-2 and MMP-7 were correlated. MMP-2 expression in stromal cells was more increased in the distal part of the colorectum: 8.8% in right colon cancer, 29.5% in left colon cancer and 36.4% in rectal cancer. MMP-2 expression of tumor cells in the tumor border was correlated with T-stage. MMP-7 expression of tumor cells in the tumor border was increased in case of infiltrative cancer compared with fungating tumor. The expression patterns of MMP-2 and -7 were not correlated with other clinicopathological factors, including tumor markers, node metastasis, distant metastasis, lymphatic invasion, tumor differentiation, and recurrence. No significant associations between the overall and disease-free survival rates and the MMP-2 and -7 expression patterns were noted.

Conclusion

The high expression rates of MMP-2 and -7 in tumor borders suggest that MMP-2 and -7 have some role in tumor invasion, but in this study, MMP-2 and -7 did not appear to be significant predictors of prognosis in colorectal cancer.

Citations

Citations to this article as recorded by  
  • A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy
    Lanlan Zong, Hongliang Xu, Huiqi Zhang, Ziwei Tu, Xiao Zhang, Shumin Wang, Meigui Li, Yu Feng, Binke Wang, Luhui Li, Xinmei Xie, Zhonggui He, Xiaohui Pu
    International Journal of Biological Macromolecules.2024; 262: 130043.     CrossRef
  • Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas
    Otto Luiz Dutra Cerqueira, Mayara Carolline Silva Botelho, Ana Paula Zen Petisco Fiore, Cynthia Aparecida Bueno de Toledo Osório, Rebeka Tomasin, Mauro César Cafundó Morais, Rossana Verónica Mendoza López, Elaine Cristina Cardoso, Santiago Andres Vilella-
    Neoplasia.2022; 30: 100803.     CrossRef
  • Effect of ginger extracts on colorectal cancer HCT-116 cell line in the expression of MMP-2 and KRAS
    Shiva Malmir, Asa Ebrahimi, Frouzandeh Mahjoubi
    Gene Reports.2020; 21: 100824.     CrossRef
  • Proteome Heterogeneity in Colorectal Cancer
    Lay Cheng Lim, Yang Mooi Lim
    PROTEOMICS.2018;[Epub]     CrossRef
  • Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males
    Mahmood Rasool, Arif Malik, Ahmad Ashar Ghuman, Muhammad Abdul Basit Ashraf, Mahwish Arooj, Sulayman Waquar, Sara Zahid, Sumera Shaheen, Aamer Qazi, Muhammad Imran Naseer, Mazin A. Zamzami, Ayat Al-Ghafari, Othman A. Baothman, Mustafa Zeyadi, Nawal Helmi,
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Circulating gelatinases are not prognostic of treatment response and survival in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
    Sukran Ulger, Diclehan Kilic, Fatih Demircioglu, Canan Y Demirtas, Ozge T. Pasaoglu
    Journal of Cancer Research and Therapeutics.2018; 14(Suppl 1): S90.     CrossRef
  • Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication
    Zbigniew Lorenc, Dariusz Waniczek, Katarzyna Lorenc-Podgórska, Wiktor Krawczyk, Maciej Domagała, Mateusz Majewski, Urszula Mazurek
    Medical Science Monitor.2017; 23: 1305.     CrossRef
  • Matrix Metalloproteinase-2 and -9, Lactate, and Malate Dehydrogenase and Lipid Peroxides in Sera of Patients with Colorectal Carcinoma
    Kristina Gopcevic, B. Rovcanin, D. Kekic, Z. Krivokapic, V. Dragutinovic
    Folia Biologica.2017; 63(5-6): 190.     CrossRef
  • CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
    Julia Lüke, Vlatka Vukoja, Tim Brandenbusch, Khaled Nassar, Jens Martin Rohrbach, Salvatore Grisanti, Matthias Lüke, Aysegül Tura
    BMC Ophthalmology.2016;[Epub]     CrossRef
  • High Expression of Matrix Metalloproteinases: MMP-2 and MMP-9 Predicts Poor Survival Outcome in Colorectal Carcinoma
    Nada Salem, Ibrahim Kamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Abdul Ali Peer-Zada, Yousif Qari, Mahmoud Al-Ahwal, Mohammed Al-Qahtani, Abdelbaset Buhmeida
    Future Oncology.2016; 12(3): 323.     CrossRef
  • Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K/AKT/MMP7 signaling pathway
    Chang-long Xu, Jian-zhang Wang, Xuan-ping Xia, Chen-wei Pan, Xiao-xiao Shao, Sheng-long Xia, Shou-xing Yang, Bo Zheng
    Biochemical and Biophysical Research Communications.2016; 470(2): 397.     CrossRef
  • Shikonin inhibits the cell viability, adhesion, invasion and migration of the human gastric cancer cell line MGC-803 via the Toll-like receptor 2/nuclear factor-kappa B pathway
    Ji Ping Liu, Dan Liu, Jun Fei Gu, Mao Mao Zhu, Li Cui
    Journal of Pharmacy and Pharmacology.2015; 67(8): 1143.     CrossRef
  • Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis
    Da-wei Sun, Ying-yi Zhang, Yue Qi, Xing-tong Zhou, Guo-yue Lv
    Cancer Epidemiology.2015; 39(2): 135.     CrossRef
  • Immunoexpression of metalloproteinase 14 and tissue inhibitor of metalloproteinase 2 in colorectal carcinomas and lymph node metastases
    Francisco Nélson Nóbrega Furtado, João Paulo Aguiar Sampaio, João Tarcisio Alves Maia-Filho, Renato Braga Vieira, Roberto César Pereira Lima-Júnior, Ronaldo Albuquerque Ribeiro, Paulo Roberto Carvalho Almeida
    Comparative Clinical Pathology.2015; 24(6): 1367.     CrossRef
  • MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine
    YE QIN, XIU-JUN LIU, LIANG LI, XU-JIE LIU, YI LI, RUI-JUAN GAO, RONG-GUANG SHAO, YONG-SU ZHEN
    Oncology Reports.2014; 32(1): 121.     CrossRef
  • Prognostic Role of Tumor-Associated Proteases in Colorectal Cancer
    N. E. Kushlinskii, E. S. Gershtein, E. A. Korotkova, V. V. Prorokov
    Bulletin of Experimental Biology and Medicine.2013; 154(3): 365.     CrossRef
  • Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver
    Yunfei Zuo, Shuangyi Ren, Min Wang, Biao Liu, Juntao Yang, Xuezhang Kuai, Changwei Lin, Dianyuan Zhao, Li Tang, Fuchu He
    Gut.2013; 62(8): 1169.     CrossRef
  • Patterns of FOXE1 Expression in Papillary Thyroid Carcinoma by Immunohistochemistry
    Andrey Bychkov, Vladimir Saenko, Masahiro Nakashima, Norisato Mitsutake, Tatiana Rogounovitch, Alyaksandr Nikitski, Florence Orim, Shunichi Yamashita
    Thyroid.2013; 23(7): 817.     CrossRef
  • Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis
    Mumu Shi, Bo Yu, Hongguo Gao, Jingwen Mu, Changwei Ji
    Molecular Biology Reports.2013; 40(1): 617.     CrossRef
Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer
Hyeong-Joon Jeon, Jin-Hee Woo, Hak-Yoon Lee, Ki-Jae Park, Hong-Jo Choi
J Korean Soc Coloproctol. 2011;27(3):140-146.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.140
  • 5,416 View
  • 46 Download
  • 9 Citations
AbstractAbstract PDF
Purpose

Great progress has been made in the adjuvant treatment of colon cancer. The aim of this study was to evaluate the efficacy of postoperative adjuvant chemotherapy using the FOLFOX regimen in patients with stage III and high-risk stage II colon cancer.

Methods

Eighty-two patients who underwent a potentially curative resection for stage III or high-risk stage II colon cancer were enrolled in this retrospective study. They received FOLFOX4 or modified FOLFOX6. The primary endpoint was disease-free survival.

Results

During the median follow-up of 37 months (range, 21 to 61 months), 14 patients experienced disease relapse. The disease-free survival rate at 3 years was 82.9%: 84.6% for stage II and 82.6% for stage III. At the time of the analysis, 8 patients were dead from recurrence. The probability of overall survival at 5 years was 74.5%: 90% for stage II and 74.6% for stage III. Grade 3 or 4 hematologic adverse events included neutropenia (40.2%), anemia (2.4%), and thrombocytopenia (1.2%). Gastrointestinal toxicities included grade 3 or 4 nausea (4.9%) and stomatitis (2.4%). Peripheral sensory neuropathy was observed in 81.7% of the patients during treatment. Of the 11 patients (13.4%) who had grade 3 peripheral sensory neuropathy during treatment, grade 3 symptoms were persistent in 3 patients with gait disturbance at the time of analysis. No treatment-related deaths were recorded.

Conclusion

Postoperative chemotherapy using the FOLFOX regimen, oxaliplatin in combination with 5-fluorouracil and leucovorin, is effective and tolerable in patients with stage III and high-risk stage II colon cancer.

Citations

Citations to this article as recorded by  
  • Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
    Shirin Kianersi, Sina Salari, Hamid Rezvani, Mohammad A. Araskhan, Alireza Shirangi, Mohammad R. Fathi, Mahmoud D. Ghorbi
    Journal of Education and Health Promotion.2023;[Epub]     CrossRef
  • Extending the boundaries of cancer therapeutic complexity with literature text mining
    Danna Niezni, Hillel Taub-Tabib, Yuval Harris, Hagit Sason, Yakir Amrusi, Dana Meron-Azagury, Maytal Avrashami, Shaked Launer-Wachs, Jon Borchardt, M. Kusold, Aryeh Tiktinsky, Tom Hope, Yoav Goldberg, Yosi Shamay
    Artificial Intelligence in Medicine.2023; 145: 102681.     CrossRef
  • Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer
    T. Quang Nguyen, T. Oanh Bui, P. Thao Tran, V. Thuan Tran, V. Hieu Nguyen, Q. Hoan Chu, T. A. Tuyet Bui, N. Quynh Le, V. Quang Le, V. Tu Dao
    Cancer Control.2019; 26(1): 107327481986411.     CrossRef
  • Operative Versus Nonoperative Management of Appendicitis: A Long-Term Cost Effectiveness Analysis
    Lindsay A. Sceats, Seul Ku, Alanna Coughran, Britainy Barnes, Emily Grimm, Matthew Muffly, David A. Spain, Cindy Kin, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert
    MDM Policy & Practice.2019; 4(2): 238146831986644.     CrossRef
  • Efficacy and clinical monitoring strategies for immune checkpoint inhibitors and targeted cytokine immunotherapy for locally advanced and metastatic colorectal cancer
    Shelby N. Bess, Gage J. Greening, Timothy J. Muldoon
    Cytokine & Growth Factor Reviews.2019; 49: 1.     CrossRef
  • Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
    Akie Watanabe, Chang Cheng Yang, Winson Y. Cheung
    Medical Oncology.2018;[Epub]     CrossRef
  • Risk Stratification in Patients with Stage II Colon Cancer
    Ramzi Amri, Jonathan England, Liliana G. Bordeianou, David L. Berger
    Annals of Surgical Oncology.2016; 23(12): 3907.     CrossRef
  • Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects
    Rachel M. McQuade, Joel C. Bornstein, Kulmira Nurgali
    International Journal of Clinical Medicine.2014; 05(07): 393.     CrossRef
  • Multiple Cancers in a Patient with Systemic Sclerosis and Aggravated Interstitial Lung Disease by Chemotherapy
    Chan Kwon Park, Seok Jong Lee, Hyung Jun Cho, Kyeong Soo Lee, Sung Jun Kim, Gu Min Cho, Ha Ni Lee
    Tuberculosis and Respiratory Diseases.2013; 75(3): 111.     CrossRef
Case Reports
Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor
Kyu Jong Yoon, Nam Kyu Kim, Kang Young Lee, Byung Soh Min, Hyuk Hur, Jeonghyun Kang, Sarah Lee
J Korean Soc Coloproctol. 2011;27(3):147-152.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.147
  • 3,893 View
  • 36 Download
  • 10 Citations
AbstractAbstract PDF

Surgery is the standard treatment for a primary gastrointestinal stromal tumor (GIST); however, surgical resection is often not curative, particularly for large GISTs. In the past decade, with imatinib mesylate (IM), management strategies for GISTs have evolved significantly, and now IM is the standard care for patients with locally advanced, recurrent or metastatic GISTs. Adjuvant therapy with imatinib was recently approved for use, and preoperative imatinib is an emerging treatment option for patients who require cytoreductive therapy. IM neoadjuvant therapy for primary GISTs has been reported, but there is no consensus on the dose of the drug, the duration of treatment and the optimal time of surgery. These are critical because drug resistance or tumor progression can develop with a prolonged treatment. This report describes two cases of large rectal malignant GISTs, for which a abdominoperineal resection was initially anticipated. The two patients received IM preoperative treatment; we followed-up with CT or magnetic resonance imaging to access the response. After 9 months of treatment, a multi-disciplinary consensus that maximal benefit from imatinib had been achieved was reached. We determined the best time for surgical intervention and successfully performed sphincter-preserving surgery before resistance to imatinib or tumor progression occurred. We believe that a multidisciplinary team approach, considerating the optimal duration of therapy and the timing of surgery, is required to optimize treatment outcome.

Citations

Citations to this article as recorded by  
  • Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study
    Xiangfei Sun, Xiaohan Lin, Qiang Zhang, Chao Li, Ping Shu, Xiaodong Gao, Kuntang Shen
    Cancer Medicine.2024;[Epub]     CrossRef
  • Clinicopathological and Immunohistochemical Characterization of Gastrointestinal Stromal Tumour at Four Tertiary Health Centers in Nigeria Using CD117, DOG1, and Human Epidermal Growth Factor Receptor-2 Biomarkers
    Mumini Wemimo Rasheed, Afolayan Enoch Abiodun, Uchechukwu Brian Eziagu, Najeem Adedamola Idowu, Abdullahi Kabiru, Taiwo Adeyemi Adegboye, Waheed Akanni Oluogun, Adekunle Adebayo Ayoade
    Annals of African Medicine.2023; 22(4): 501.     CrossRef
  • Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature
    Qiang Sun, Ning Su, Xinxing Li, Zhiqian Hu, Weijun Wang
    Asia-Pacific Journal of Clinical Oncology.2020; 16(3): 123.     CrossRef
  • Using endoscopy to minimize the extent of resection in the management of giant GISTs of the stomach
    Hishaam Ismael, Yury Ragoza, Steven Cox
    International Journal of Surgery Case Reports.2017; 36: 26.     CrossRef
  • Combined Therapy of Gastrointestinal Stromal Tumors
    Piotr Rutkowski, Daphne Hompes
    Surgical Oncology Clinics of North America.2016; 25(4): 735.     CrossRef
  • Indications for surgery in advanced/metastatic GIST
    Samuel J. Ford, Alessandro Gronchi
    European Journal of Cancer.2016; 63: 154.     CrossRef
  • Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib
    M J Wilkinson, J E F Fitzgerald, D C Strauss, A J Hayes, J M Thomas, C Messiou, C Fisher, C Benson, P P Tekkis, I Judson
    British Journal of Surgery.2015; 102(8): 965.     CrossRef
  • Intolerance to Imatinib in Gastrointestinal Stromal Tumors: A Case Report and a Review of Literature
    Yousra Akasbi, Samia Arifi, Sami Aziz Brahmi, Fatima Zahra El Mrabet, Nawfel Mellas, Fatima Zahra Mernisi, Omar El Mesbahi
    Journal of Gastrointestinal Cancer.2014; 45(S1): 71.     CrossRef
  • Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group
    Thanh-Khoa Huynh, Pierre Meeus, Philippe Cassier, Olivier Bouché, Sophie Lardière-Deguelte, Antoine Adenis, Thierry André, Julien Mancini, Olivier Collard, Michael Montemurro, Emmanuelle Bompas, Maria Rios, Nicolas Isambert, Didier Cupissol, Jean-Yves Bla
    BMC Cancer.2014;[Epub]     CrossRef
  • Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
    Piotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, Sylvie Bonvalot, Patrick Schöffski, Sebastian Bauer, Elena Fumagalli, Pawel Nyckowski, Buu-Phuc Nguyen, Jan Martijn Kerst, Marco Fiore, Elzbieta Bylina, Mathias Hoiczyk, Annemieke Cats, Paolo G. Casa
    Annals of Surgical Oncology.2013; 20(9): 2937.     CrossRef
Acute Abdomen Caused by an Infected Mesenteric Cyst in the Ascending Colon: A Case Report
Eun-Ji Kim, Seung-Hyun Lee, Byung-Kwon Ahn, Sung-Uhn Baek
J Korean Soc Coloproctol. 2011;27(3):153-156.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.153
  • 3,660 View
  • 38 Download
  • 15 Citations
AbstractAbstract PDF

Mesenteric cysts are rare intra-abdominal tumors. Mesenteric cysts are usually asymptomatic and are incidentally detected during physical or radiological examination. Although uncommon, complications such as infection, bleeding, torsion, rupture and intestinal obstruction cause an acute abdomen. Spontaneous infection is a very rare complication. We present a case of infected mesenteric cysts in the ascending colon, which caused an acute abdomen. A 26-year-old woman was admitted to our hospital with acute abdominal pain. She had a painful mass in the right abdomen on physical examination. Abdominal computed tomography showed a hypodense cystic mass with septation at the mesenteric region of the ascending colon. A laparotomy revealed two cystic tumors at the mesenteric region of the ascending colon. She underwent a right hemicolectomy. The two cysts were filled with a yellowish turbid fluid. The walls of both two cysts were lined with a thin fibrotic membrane without any epithelial cell. They were diagnosed as psuedocysts with E. coli infection. Mesenferic cysts may cause life-threatening complications. Mesenteric cyst, even if it is asymptomatic and was diagnosed incidentally, should be removed completely.

Citations

Citations to this article as recorded by  
  • Infected Mesenteric Cysts: A Rare Cause of Abdominal Pain
    Abhishek S Satpathy, Kailash C Mohapatra
    Cureus.2024;[Epub]     CrossRef
  • Non-organ mesothelial cyst of the abdominal cavity. Clinical observation
    I. V. Matveev, M. A. Danilov, N. S. Karnaukhov, A. V. Maksimenko, A. V. Leontiev, A. M. Valieva, V. V. Tsvirkun
    Surgery and Oncology.2023; 13(3): 44.     CrossRef
  • Sigmoid mesenteric cyst of urogenital origin: A rare cause of bilateral hydroureter
    Allan M. F. Kwok, Neryan A. Thomas, Stephen R. Smith
    ANZ Journal of Surgery.2022; 92(4): 884.     CrossRef
  • Bleed into an Undiagnosed Mesenteric Cyst Following Mesh Repair for Incisional Hernia
    Riju Ramachandran, Vaishnavi Gunasekaran, Anoop Vasudevan Pillai, Biju Chandran
    Kerala Surgical Journal.2021; 27(1): 105.     CrossRef
  • A case report: Acute abdominal pain caused by a mesenteric cyst in a 20 years old female patient
    Irene Cantarero Carmona, José Fernando Trebollé, Daniel Milian García, María José Luesma Bartolomé
    Annals of Medicine and Surgery.2020; 50: 28.     CrossRef
  • Perforated Mesenteric Cyst with Sepsis and Neurological Complication in a 9 Month Old Child
    Mandal KC, Saha D, Halder P, Chakraborty P, Debnath B, Mukhopadhyay B
    Asploro Journal of Pediatrics and Child Health.2020; 2(1): 30.     CrossRef
  • Mesenteric cyst: an uncommon cause of acute abdomen
    Tamara G. Mullaney, Basil D'Souza
    ANZ Journal of Surgery.2019;[Epub]     CrossRef
  • Mesenteric Cysts of Ascending, Descending, and Sigmoid Mesocolons: a Unique Case
    S. K. Pattanaik
    Indian Journal of Surgery.2018; 80(4): 382.     CrossRef
  • Mesenteric cystic lymphangioma: a case report
    Alireza Mohammadzadeh, Fatemeh Samiee-rad, Kamran Soleimanitadi
    Comparative Clinical Pathology.2018; 27(2): 545.     CrossRef
  • Acute Abdominal Pain Caused by an Infected Mesenteric Cyst in a 24-Year-Old Female
    Davy R. Sudiono, Joep B. Ponten, Frank M. Zijta
    Case Reports in Radiology.2016; 2016: 1.     CrossRef
  • Pseudoquiste mesentérico infectado en yeyuno: reporte de un caso
    Martín Adrián Bolívar-Rodríguez, Marcel Antonio Cazarez-Aguilar, Eduardo Esaú Luna-Madrid, Fred Morgan-Ortiz
    Cirugía y Cirujanos.2015; 83(4): 334.     CrossRef
  • Infected jejunal mesenteric pseudocyst: A case report
    Martín Adrián Bolívar-Rodríguez, Marcel Antonio Cazarez-Aguilar, Eduardo Esaú Luna-Madrid, Fred Morgan-Ortiz
    Cirugía y Cirujanos (English Edition).2015; 83(4): 334.     CrossRef
  • A case of mesenteric cyst confused with ovarian endometrioma
    Se Ik Kim, Young Dae Kim, Hye Seung Lee, Byung Chul Jee
    Korean Journal of Obstetrics & Gynecology.2012; 55(9): 683.     CrossRef
  • Ovarian undifferentiated carcinoma with voluminous mesenteric presentation
    Rosa Angélica Salcedo-Hernández, Leonardo Saúl Lino-Silva, David Cantú de León, María Delia Pérez-Montiel, Kuauhyama Luna-Ortiz
    International Journal of Surgery Case Reports.2012; 3(11): 551.     CrossRef
  • A case of mesenteric cyst confused with ovarian endometrioma
    Se Ik Kim, Young Dae Kim, Hye Seung Lee, Byung Chul Jee
    Korean Journal of Obstetrics & Gynecology.2012; 55(9): 683.     CrossRef
Concurrent Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Ascending Colon: A Case Report
Yo Na Kim, Ho Sung Park, Kyu Yun Jang, Woo Sung Moon, Dong Geun Lee, Ho Lee, Min Ro Lee, Kyung Ryoul Kim
J Korean Soc Coloproctol. 2011;27(3):157-161.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.157
  • 3,459 View
  • 21 Download
  • 9 Citations
AbstractAbstract PDF

Large cell neuroendocrine carcinomas of the colon are rare and represent only a small percentage of all colonic endocrine tumors. Here, we report a case of a colonic large cell neuroendocrine carcinomas concurrent with a colonic adenocarcinoma. A 70-year-old man presented with acute abdominal pain. A spiral computed tomography scan of the abdomen revealed eccentric wall thickening on the ascending colon. An explorative laparotomy and a right hemicolectomy were performed. Grossly, two separated masses were observed in the proximal ascending colon. One was a 7.4 × 5.1 cm ulcerative fungating lesion, and the other was a 2.8 × 1.9 cm polypoid lesion. Microscopically, the ulcerative fungating lesion showed a well-differentiated neuroendocrine morphology with necrosis and increased mitosis. Most of the tumor cells had large, vesicular nuclei with eosinophilic nucleoli, variable amounts of eosinophilic cytoplasm, and immunoreactivity for chromogranin A and synaptophysin. The polypoid lesion was a well-differentiated adenocarcinoma that had invaded the submucosa. We diagnosed these lesions as a concurrent large cell neuroendocrine carcinoma and an adenocarcinoma of the ascending colon.

Citations

Citations to this article as recorded by  
  • Large cell neuroendocrine tumor of the gastrointestinal tract with concurrent tubular adenomas
    Inayat GILL, Christienne SHAMS, Elisa QUIROZ, Subhashree M. KRISHNAN, Susanna GAIKAZIAN
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2021;[Epub]     CrossRef
  • Large cell neuroendocrine carcinoma of the colon with brain metastasis: A case report
    Ali Allouch, Mohamad K. Moussa, Ali Dirany, Zahraa Barek, Mohammad Makke, Nizar Bitar
    International Journal of Surgery Case Reports.2020; 76: 421.     CrossRef
  • A case of colorectal large cell neuroendocrine carcinoma accompanied by disseminated peritoneal leiomyomatosis
    Kunihiko Suga, Hiroomi Ogawa, Makoto Sohda, Chika Katayama, Naoya Ozawa, Katsuya Osone, Takuhisa Okada, Takuya Shiraishi, Ryuji Katoh, Akihiko Sano, Makoto Sakai, Takehiko Yokobori, Ken Shirabe, Hiroshi Saeki
    Surgical Case Reports.2020;[Epub]     CrossRef
  • Colorectal neuroendocrine carcinoma: A case report and review of the literature
    Tomoaki Yoshida, Kenya Kamimura, Kazunori Hosaka, Koji Doumori, Hiromitsu Oka, Akito Sato, Yasuo Fukuhara, Shoji Watanabe, Tomomi Sato, Akira Yoshikawa, Takashi Tomidokoro, Shuji Terai
    World Journal of Clinical Cases.2019; 7(14): 1865.     CrossRef
  • Neuroendocrine tumor mixed with adenoma in rectum: a case report and literature review
    Jiancong Hu, Xiaochuan Chen, Dezheng Lin, Zhaoliang Yu, Juan Li, Xuefeng Guo
    International Journal of Surgery Oncology.2019; 4(6): e79.     CrossRef
  • Large Cell Neuroendocrine Carcinoma of the Rectum with Long Recurrence-free Survival after Radical Surgery and Adjuvant Chemotherapy
    Kukiko SAKIHAMA, Kinuko NAGAYOSHI, Hayato FUJITA, Shuntaro NAGAI, Yoshinao ODA, Masafumi NAKAMURA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2018; 79(12): 2463.     CrossRef
  • Synchronous Small Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Colon: A Link for Common Stem Cell Origin?
    Seth Lipka, Jorge Hurtado-Cordovi, Boris Avezbakiyev, Lester Freedman, Toshimasa Clark, Kaleem Rizvon, Paul Mustacchia
    ACG Case Reports Journal.2014; 1(2): 96.     CrossRef
  • Simultaneous Neuroendocrine Carcinoma and Adenocarcinoma of the Colon
    Donggeum Shin, Youngsook Park, Soojung Gong, Seonghwan Kim, Yunju Jo, Sangbong Ahn, Joonkil Han, Eunkyung Kim
    Intestinal Research.2013; 11(2): 137.     CrossRef
  • Synchronous Occurrence of Advanced Neuroendocrine Carcinoma and Tubular Adenocarcinoma of the Rectum
    Yoshifumi Nakayama, Takayuki Torigoe, Noritaka Minagawa, Toshihito Uehara, Koji Yamaguchi
    Case Reports in Gastroenterology.2013; 7(1): 117.     CrossRef

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP